Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
Breadcrumb Trail Links PMN Press Releases Business Wire News Releases Author of the article: Published May 07, 2024 • 11 minute read Article content Phase 1 MYTHIC clinical trial of lunresertib in combination with camonsertib demonstrated a significant …